POR On-Target Side Effects of Targeted Therapeutics of Cancer

The concept of precision medicine is based on the identification of hallmarks of cancer to exploit them as drug targets. The basic idea was that in this way the therapeutic modalities will be more effective and the side effects will be less. Since the majority of these novel modalities are not specific for a cancer-related biological process or a cancer-specific (mutant) target protein, it is not a surprise that we had to learn new type of side effects, because these therapeutics also affect physiological or pathological processes. Even more, in cases of some of these novel therapies we were able to discover new molecular mechanisms of physiological and pathological processes. Identification of the on-target side effects of targeted drugs can help to prevent the development of them or better manage the patients when emerge during cancer therapy.

Side effects of targeted treatments: clinicians' perceptions, patients' realities

Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association

Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms, Journal of Nanobiotechnology

Targeted cancer therapies The College of Family Physicians of Canada

Common side effects associated with targeted therapy and immunotherapy

Targeted Therapy for Cancer - NCI

Targeted Therapy & Hormone Therapy - Taking the Mystery Out of Breast Cancer

Targeted Therapies in Cancer

Targeted Therapies for Breast Cancer

Targeted Therapy in Ovarian Cancer Published in healthbook TIMES Oncology Hematology

Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine - ScienceDirect